1）Manufacturing CapabilitiesChongqing RuiZhe Pharmaceutical Co., Ltd. (hereinafter referred to RuiZhe Pharmaceutical), wasfounded in Changshou District, Chongqing in 2012. As CPRI’s pilot scale-up manufacturing site, it is also well known for being one of new drug industrialization andincubation base in Chongqing. Ruizhe has been mostly engaged in process development activities for high-tec,high value-added API and advanced intermediates by adopting a patent designing-around strategy to support manufacturing process development enabling our customer to file an ANDA application with PIV certification. Key products had been regulatory approved by US FDA, CFDA, EDQM, Korea FDA, Japan PMDA andAustralia TGA, 80% of which exported overseas to US/EU market. Ruizhe had been constructed in ...